SCM in a Pharmaceutical Company

Tanguy Caillet ()
Additional contact information
Tanguy Caillet: Wirtschaftsprüfungsgesellschaft

Chapter 25 in Supply Chain Management and Advanced Planning, 2015, pp 459-474 from Springer

Abstract: Abstract Competitive advantage in the pharmaceutical industry is driven by first class research and development and by optimised supply chain operations. Harmonised SCM processes, systems and organisations will lead to reduced inventories, increased capacity utilization, reduced order lead time, less obsolescences and lower IT system maintenance costs. Critical decisions can be made faster resulting in an improved customer service level. Based on common, standardised data, error rates are reduced and most importantly, full FDA CFR 21 part 11 and GMP compliance can be guaranteed and sustained.

Keywords: Supply Chain; Master Planning; Master Data; Master Planner; Detailed Schedule (search for similar items in EconPapers)
Date: 2015
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sptchp:978-3-642-55309-7_25

Ordering information: This item can be ordered from
http://www.springer.com/9783642553097

DOI: 10.1007/978-3-642-55309-7_25

Access Statistics for this chapter

More chapters in Springer Texts in Business and Economics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().